https://www.selleckchem.com/products/ml210.html
high risk population. The global burden of oral squamous cell carcinoma (OSCC) remains formidable. Identifying factors predictive of aggressive tumour behaviour, disease progression and reduced survival time may assist in early identification of "high-risk" patients and appropriately target combination cancer therapies. A retrospective review of 467 OSCC patients treated over a 19-year period facilitated detailed clinico-pathological database analysis and determination of clinical outcome categories based upon time to progressive disease
Like
Comment
Share
